Clinical Outcomes for Patients with Diffuse Large B-cell Lymphoma Treated with Radiation Therapy and Lenalidomide

被引：0
|
作者：
Kim, Sungjune [1 ]
Shah, Shreni [2 ]
Yu, Su-Yuan [3 ]
Mills, Matthew [1 ]
Figura, Nicholas [1 ]
Robinson, Timothy [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[2] USF Morsani Coll Med, Tampa, FL USA
[3] Univ S Florida, Morsani Coll Med, Tampa, FL 33620 USA
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2021年 / 44卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P130
引用
下载
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [21] Impact of Circulating Lymphoma at Diagnosis on Outcomes in Patients with Diffuse Large B-Cell Lymphoma
    Rajamouli, Srichandhana
    McLaughlin, Eric
    Hanel, Walter
    Bond, David A.
    Sawalha, Yazeed
    Voorhees, Timothy J.
    Alinari, Lapo
    Sehgal, Lalit
    Maddocks, Kami J.
    Christian, Beth
    Jones, Daniel
    Epperla, Narendranath
    BLOOD, 2022, 140 : 6659 - 6660
  • [22] Diffuse large B-cell lymphoma - Molecular heterogeneity of diffuse large B-cell lymphoma
    Gascoyne, RD
    HEMATOLOGY JOURNAL, 2004, 5 : S144 - S148
  • [23] Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
    Wang, Yucai
    Farooq, Umar
    Link, Brian K.
    Larson, Melissa C.
    King, Rebecca L.
    Maurer, Matthew J.
    Allmer, Cristine
    Hefazi, Mehrdad
    Thompson, Carrie A.
    Micallef, Ivana N.
    Johnston, Patrick B.
    Habermann, Thomas M.
    Witzig, Thomas E.
    Ansell, Stephen M.
    Cerhan, James R.
    Nowakowski, Grzegorz S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (21) : 1819 - +
  • [24] DIFFUSE LARGE B-CELL LYMPHOMA IN GLIOMA PATIENTS TREATED WITH TEMOZOLOMIDE CHEMOTHERAPY
    Cordera, S.
    Bottacchi, E.
    Alvaro, M.
    Joossens, E.
    Neyns, B.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1119 - 1120
  • [25] Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel
    Andreadis, Charalambos
    Tam, Constantine S.
    Borchmann, Peter
    Jaeger, Ulrich
    McGuirk, Joseph P.
    Holte, Harald
    Waller, Edmund K.
    Jaglowski, Samantha
    Bishop, Michael R.
    Foley, Stephen Ronan
    Westin, Jason R.
    Fleury, Isabelle
    Ho, P. Joy
    Mielke, Stephan
    Teshima, Takanori
    Salles, Gilles A.
    Schuster, Stephen J.
    Bachanova, Veronika
    Maziarz, Richard T.
    Van Besien, Koen
    Izutsu, Koji
    Magenau, John M.
    Wagner-Johnston, Nina D.
    Kato, Koji
    Corradini, Paolo
    Tiwari, Ranjan
    Awasthi, Rakesh
    Lawniczek, Tomasz
    Eldjerou, Lamis K.
    Kersten, Marie Jose
    BLOOD, 2019, 134
  • [26] Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma
    Rodgers, Thomas D.
    Baran, Andrea
    Reagan, Patrick M.
    Casulo, Carla
    Zent, Clive
    Evans, Andrew
    Burack, Richard
    Williams, AnnaLynn M.
    Friedberg, Jonathan W.
    Barr, Paul M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : E33 - +
  • [27] Efficacy and safety of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma
    Habermann, T.
    Lossos, I.
    Justice, G.
    Tuscano, J.
    Cole, C.
    Vose, J.
    Pietronigro, D.
    Takeshita, K.
    Ervin-Haynes, A.
    Zeldis, J.
    Wiernik, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 150 - 150
  • [28] Role of consolidative radiation therapy for patients with mediastinal diffuse large B-cell lymphoma in the rituximab era
    Sert, Fatma
    Kamer, Serra
    Saydam, Guray
    Anacak, Yavuz
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (06) : 1397 - 1402
  • [29] The rationale and role of radiation therapy in the treatment of patients with diffuse large B-cell lymphoma in the Rituximab era
    Wirth, Andrew
    LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2121 - 2136
  • [30] Treatment outcomes in older patients with systemic diffuse large B-cell lymphoma
    Brien, Caragh
    Zareen, Ferkhanda
    Bruce, David
    Jayaprakash, Ram
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 181 - 182
12345